Dizal Scores First JAK1 Approval For Advanced PTCL

China Nod

 
• By Dexter Jie Yan
  
first line treatment
Dizal's golidocitinib becomes world’s first approved JAK1 inhibitor for second-line PTCL • Source: Shutterstock

More from China

More from Focus On Asia